Human pluripotent stem cells (hPSCs) can give rise to all cell types in the body and therefore hold enormous potential for tissue engineering, regenerative medicine and disease modeling. Several major initiatives are under way around the world to produce human induced pluripotent stem cells (hiPSCs) at large scales 1,2 . The growing numbers of hiPSC and human embryonic stem cell (hESC) lines are increasing access to hPSCs for researchers and should facilitate progress toward therapeutic applications 3 . These developments underscore the importance of devising hPSC quality standards that are sufficiently stringent to ensure comparable and reproducible results across laboratories 4 . The need for a scalable, quantitative assay of pluripotency is becoming ever more acute as the number of lines, culture conditions and hPSC laboratories continue to increase and as therapies based on hPSCs are advanced to clinical translation.
A r t i c l e s
Human pluripotent stem cells (hPSCs) can give rise to all cell types in the body and therefore hold enormous potential for tissue engineering, regenerative medicine and disease modeling. Several major initiatives are under way around the world to produce human induced pluripotent stem cells (hiPSCs) at large scales 1, 2 . The growing numbers of hiPSC and human embryonic stem cell (hESC) lines are increasing access to hPSCs for researchers and should facilitate progress toward therapeutic applications 3 . These developments underscore the importance of devising hPSC quality standards that are sufficiently stringent to ensure comparable and reproducible results across laboratories 4 . The need for a scalable, quantitative assay of pluripotency is becoming ever more acute as the number of lines, culture conditions and hPSC laboratories continue to increase and as therapies based on hPSCs are advanced to clinical translation.
Formation of teratomas in mice is the gold standard assay for characterizing the differentiation potential of hPSCs. However, the generation of teratomas requires large numbers of mice and is not scalable to the number of hPSC lines that will be created in the years to come. Moreover, it is a time-consuming assay whose results are highly variable and difficult to quantify 4, 5 . Recent studies have begun to use genomic approaches 6, 7 as a more quantitative, efficient way to assess the quality and potential of hPSCs. Although these approaches share the principle of gene expression signatures, they measure distinct aspects of pluripotency. PluriTest 6 measures the molecular signature of pluripotency and uses this to classify pluripotent samples with great sensitivity and specificity. In contrast, the ScoreCard 7 approach evaluates the molecular signature of pluripotency and expression signatures that indicate functional pluripotency, defined as differentiation into each of the three germ layers. However, the initial ScoreCard was not optimized for early germ layer differentiation, used NanoString's nCounter technology that is not available to most laboratories, and required customized downstream analysis, restricting its adoption by the community.
To overcome these limitations, we developed a more accessible ScoreCard assay that uses qPCR measurements of a revised set of genes and provides improved statistical analysis, accuracy and utility for a wider array of applications. We demonstrate applications, including directed differentiation and quantitative screening experiments, that would not be possible using the previous genomic approaches 6, 7 . Our results further support the advantages of gene expression measurements for the rapid and quantitative characterization of cell types, lineage regulators and culture conditions.
RESULTS

Characterization of hPSC lines using standard assays
To establish a reference point, we selected five commonly used hESC lines from the NIH registry that have shown some variability in their differentiation potential in the past 7, 8 and performed standard assays to characterize them. All lines displayed typical morphology (Fig. 1a , top row) and stained positive for the pluripotency-associated markers OCT4 and TRA1-60 (Fig. 1a, bottom rows) . We next performed global expression analysis using RNA-seq of polyadenylated transcripts ( Fig. 1b and Supplementary Table 1 ) and found expression levels of selected pluripotency-associated markers to be 10-1,000 times higher than those of known markers of early differentiation, supporting the molecular pluripotency of these lines. We also performed karyotyping (Supplementary Fig. 1a ) and injected the five hESC lines A qPcr scorecard quantifies the differentiation potential of human pluripotent stem cells Research on human pluripotent stem cells has been hampered by the lack of a standardized, quantitative, scalable assay of pluripotency. We previously described an assay called ScoreCard that used gene expression signatures to quantify differentiation efficiency. Here we report an improved version of the assay based on qPCR that enables faster, more quantitative assessment of functional pluripotency. We provide an in-depth characterization of the revised signature panel (commercially available as the TaqMan hPSC Scorecard Assay) through embryoid body and directed differentiation experiments as well as a detailed comparison to the teratoma assay. We further show that the improved ScoreCard enables a wider range of applications, such as screening of small molecules, genetic perturbations and assessment of culture conditions. Our approach can be extended beyond stem cell applications to characterize and assess the utility of other cell types and lineages.
as well as an additional hiPSC line (1-51C) into the kidney capsule of immunocompromised mice for teratoma formation ( Fig. 1c and Supplementary Fig. 1b) , which confirmed the functional pluripotency of the selected lines.
To obtain a more accurate and quantitative assessment, we performed detailed pathology analysis using high-throughput imaging (Fig. 1c, Supplementary Fig. 2 A r t i c l e s contained a much higher fraction of tissues derived from ectoderm (EC) and mesoderm (ME) than from endoderm (EN), which appears to be consistent across all lines and replicates that we studied (Fig. 1d) . This information is not provided by standard teratoma analysis. Lastly, the teratoma assay showed an inherent variability between biological replicates (same cells, but different mice injected) and even between different sections of the same teratoma. The fraction of EC-and MEderived nuclei varied between biological replicates of lines HUES64 and H9, whereas technical replicates H9_1a and H9_1b were highly similar (Fig. 1d) . The within-group variability between replicates for the percentage of EC and ME nuclei (σ EC = 16%; σ ME = 20%) was similar to the variability between cell lines (σ EC = 21%; σ ME = 20%). Samples also showed high variation between different teratoma sections (σ EC = 15%; σ ME = 14%) in the pathology quantification ( Fig. 1e ) and in the RNA expression level of germ layer-specific marker genes (Fig. 1f) . Taken together, the results clearly established the pluripotency of all lines, but despite detailed analysis, the teratomas provided only limited quantitative information to make meaningful statements about the quality of the chosen lines.
Gene expression signatures using a qPCR panel
We have previously shown that gene expression signatures can effectively quantify the differentiation potential of hPSC lines 7 . To improve and expand this approach, we designed a qPCR-based assay for measuring total RNA level of 96 carefully selected genes. Our design included 13 probes serving as controls, including for detection of contamination and for data normalization, as well as gene markers for pluripotent stem cells (PL), mesendoderm (MS) and the three embryonic germ layers, EN, ME and EC (9, 6, 22, 25 and 21 genes, respectively; Fig. 2a and Supplementary Fig. 3a) . Markers of the three germ layers were chosen based on their uniqueness of expression according to RNA-seq data 9 from purified HUES64-derived EN, ME and EC populations (Online Methods). Notably, this approach allowed us to select germ layer markers with 8-to 16-fold higher mean uniqueness of expression than those in the previous ScoreCard panel 7 ( Supplementary Fig. 3b ). Although the markers were selected based on HUES64 data 9 , the uniqueness of expression for the chosen genes correlated very well with the mean uniqueness of expression across all profiled hPSC lines (Supplementary Fig. 3c ). We next obtained TaqMan plates containing the selected genes and confirmed that expression levels were highly reproducible between technical replicates on different plate lots and for lower RNA input (Supplementary Fig. 4a ).
Next we expanded our sample set to 23 hPSC lines, which we differentiated into embryoid bodies by withdrawing growth factors in suspension. RNA was collected from cells in the undifferentiated state (day = 0) as well as at 2, 5 and 12 days after differentiation. Biological replicates of our embryoid body time course for cell lines with similar passage numbers and more than ten passages apart were well correlated in gene expression values (R > 0.92, Supplementary  Fig. 4b,c) . We then normalized the data against the expression of five housekeeping probes that were most invariant across >80 experiments (Supplementary Table 3 ). The normalization technique reduced variance between replicates of the same cell lines relative to the variance between different cell lines (Supplementary Fig. 4d ).
Characterizing embryoid body differentiation potential
To quantify differentiation potential using embryoid body formation across cell lines, we improved our previous computational analysis 7 . Specifically, for each gene in an embryoid body experiment, we compared its expression relative to the expression of that gene prior to differentiation for a reference set of the 23 hPSC lines and calculated a P value P k (t-test; Fig. 2a , middle). The resulting P values were then merged within each gene set (PL, EN, ME and EC) using the weighted Z-method 10 (Fig. 2a, right) , which combines the information across multiple statistical tests of the same null hypothesis, weighing tests based on their importance and taking into account dependencies between tests. Weights were set to the average cell line expression difference between day 5 or 12 of embryoid body formation and day 0 (Supplementary Table 4) , and genes with negative weights were excluded from the analysis. A scatter plot of day 5 and day 12 weights showed a strong correlation between them (R = 0.93, Fig. 2b) . We refer to the weighted Z-test standard normal deviate Z w,GS for each gene set GS as the differentiation potential EB , which measures the distance traveled by the embryoid body (EB) population away from a pluripotent state.
The differentiation potential EB for the three germ layers gradually increased during the embryoid body differentiation time course (Fig. 2c) , with endoderm induction lagging behind mesoderm and ectoderm. At day five, 14 of the 23 lines showed significant increases in expression of EC, ME and EN gene markers (P < 0.05, Fig. 2d) . At day 12, all 23 lines showed significant (P < 0.005) differential expression from the pluripotent state for all three germ layers (Fig. 2d, right) , consistent with previous functional characterization of these lines 7, 11 . Based on this result, we chose day 12 for the quantification of differentiation potential EB in the subsequent experiments. The weighted Z-method increased the overall differentiation potential EB and the significance of the combined P value for most cell lines when compared with the Stouffer's (unweighted) Z-transform test 12 ( Supplementary Fig. 4e,f) . To contrast the established pluripotent lines, we obtained several partially reprogrammed iPSC (PiPSC) lines and quantified their differentiation potential (Fig. 2c,d bottom) . Prior to differentiation, these lines' germ layer differentiation potential EB was in the range of other hPSC lines. Not surprisingly, after 5 or 12 days of embryoid body differentiation, the PiPSCs were unable to activate germ layer markers in the same manner as hPSCs ( Fig. 2c,  bottom; Supplementary Fig. 4g ). Notably, we detected a weak signal for ME differentiation, likely because these cell lines were reprogrammed from human fibroblasts, a mesodermal tissue.
To calculate the minimum number of genes needed to accurately measure differentiation potential EB , we performed feature selection using the Lasso regression algorithm (Supplementary Fig. 5a-c) . We found that 12 EC, 8 ME, 9 EN and 5 PL markers were sufficient to calculate a near-perfect fit to differentiation potential EB with only a slight decrease in statistical power (Supplementary Fig. 5d ). Hierarchical clustering of day 0 and day 12 embryoid body differentiation expression showed a clear separation between the two time points (Fig. 2e) . It also showed that a subset of lines had specific gene expression programs. Cell lines iPS11C, HUES53 and HUES65 had significantly lower EC expression (P < 10 -10 , weighted Z-method) compared to the other cell lines as shown for several key marker genes (Fig. 2e , top right box) and also the lowest EC differentiation potential EB at day 12 (Fig. 2c,d) .
To assess the stability of the scores and study the effect of continued cell culture on differentiation, we selected three cell lines and passaged them continuously for more than ten passages. We found that expression signatures remained highly consistent for each cell line, with stronger sample similarity within than between groups (Fig. 2f) . We also found that the differentiation potential EB remains largely similar, with a slight increase of the mesoderm signal for later passages of H1 and H9 differentiation (Fig. 2g) . To compare the predictive power of cell line differentiation potential as quantified by both the teratoma npg and qPCR assays, we calculated the variance in assay scores between cell lines (between groups) and between replicates of the same cell lines (within group). The between-and within-group variances for teratoma germ layer scores quantified using our pathology analysis or using teratoma gene expression measurements via our signature panel were very similar ( Fig. 2h, left ; P > 0.2, F-test). In contrast, embryoid body differentiation potential variance between replicates was significantly less than variance between cell lines, even when considering replicates over ten passages apart (Fig. 2h, right ; P < 0.0005, F-test). We also found that embryoid body formation using the same protocol but with hPSC line stocks from different laboratories can vary in their embryoid body differentiation potential, such that expression signatures are more similar between different lines within the same laboratory than between the same cell lines from different laboratories (Fig. 2i) . Taken together, our results show that our qPCR-based measure of cell lines' germ layer propensity is more quantitative and reproducible than the teratoma assay, even when the cell line has remained in culture for several passages; however, different cell line stocks in different laboratories can have very different starting propensities.
Temporal signature dynamics in embryoid body differentiation Along with variation in differentiation potential EB between cell lines, we also observed differences in induction dynamics during embryoid body formation. For example, H9 activated EC genes and repressed PL markers by day 5, whereas H1 achieved similar levels of EC induction and PL repression more gradually (Fig. 3a) . To further characterize these induction dynamics, we calculated the ratio of day 5 to day 12 mean gene expression (Fig. 3b) , averaged across all markers within each germ layer. Ratios near or above 1 indicate rapid induction, and ratios near or below 0 indicate delayed germ layer response. This analysis confirmed that H9 activated EC markers faster than H1 (Fig. 3b) , and that H9 repressed PL markers more rapidly than H1 (Supplementary Fig. 6a ). The embryoid body gene expression dynamics correlated very well (R > 0.95) with differentiation potential EB dynamics for the three germ layers (Supplementary Fig. 6b,c) , calculated using the ratio of Z w,GS day 5 to day 12. We also note that fast induction did not necessarily coincide with high differentiation potential EB , as iPSC11C had a rapid EN induction at day 5 but the second lowest EN differentiation potential EB .
To visualize these embryoid body differentiation dynamics in orthogonal vector space, we performed principal component analysis (PCA) of our day 0, 5 and 12 data (Fig. 3c) . We found that the first principal component (x axis) followed the path of differentiation, as cell lines increased their component 1 scores from day 0 to day 12 ( Fig. 3c,d) . Furthermore, we mapped the direction of EN, ME and EC differentiation by weighted averaging of the loadings for the marker genes of the respective germ layer (Fig. 3d) . Among the six selected cell lines, HUES53 advanced primarily in the direction of the ME vector while traveling the shortest distance along the component 1 axis, which indicates that it is ineffective in repressing PL genes and activating EC and EN markers. Moreover, H9 and HUES64 had a strong EC propensity at day 0, which in H9 persisted through day 12, whereas HUES64 moved in the ME/EN direction, activating those markers more effectively.
To quantify embryoid body dynamics for each gene, we calculated the RNA expression ratios of day 2 to day 12 and day 5 to day 12, averaged across the 23 reference cell lines. Positive ratios represent gene induction, whereas negative scores represent overall repression in embryoid body differentiation (Fig. 3e) . We found that several genes were induced transiently at day 2 only (PAPLN, FGF4) or at both day 2 and day 5 (CDH9, DMBX1, CABP7), whereas others were transiently repressed at day 2 and day 5. Comparison of day 12 and day 5 weights with those of day 2 can also be used to visualize gene dynamics on a scatter plot ( Supplementary Fig. 6d ,e). In summary, our embryoid body dynamics analysis revealed rapid activation of EC by day 5 of embryoid body formation, more gradual activation of ME that reached the highest differential potential EB at day 12 and a delayed EN response.
Assessing directed differentiation of hPSCs
Next, we studied directed differentiation of 14 hPSC lines into derived endoderm (dEN), mesoderm (dME) and ectoderm (dEC) populations in two-dimensional (2D) culture 9, 13 . Hierarchical clustering of the data (Fig. 4a, columns) and PCA along the first two components (Fig. 4b, top) both showed clear separation between data sets for the germ layers. Furthermore, clustering of the genes (Fig. 4a , rows) aggregated markers from the same germ layers across all experiments. As expected, some pluripotent markers intermixed with markers from EN but not the other two germ layers. Similarly, PCA showed that undifferentiated populations mapped most closely to dEN and dEC data whereas dME experiments separated the most along the direction of the first component ( Fig. 4b) , which is consistent with prior RNA-seq analysis 9 . Mapping the directions of the marker genes (Fig. 4b , bottom) showed that H1 and H9 differentiated most effectively into dEC whereas iPSC1-51C moved along the direction of dME the least. 
A r t i c l e s
To quantify the 2D differentiation potential, we made several small modifications to our embryoid body differentiation potential calculation ( Supplementary Fig. 7a ). First, we changed the reference set to the undifferentiated, control populations of the 2D experiments for 11 established hPSC lines (top 11 lines in Fig. 4c ). Also, we assigned the 2D weights based on cell type uniqueness of expression for each marker. The 2D weighted Z-method standard normal deviate for each gene set represents the differentiation potential 2D . Each of the lines we profiled had a highly positive differentiation potential 2D at day 5 ( Fig. 4c , left) and a significant combined P value (P < 0.002, Fig. 4c , right), which was not the case when using the unweighted Z-transform test (Supplementary Fig. 7b) . Moreover, the differentiation potential 2D for gene sets outside the pertinent 2D germ layer could quantify the amount of background expression of the other EC ME EN PL EC ME EN PL EC ME EN PL EC ME EN PL EC ME EN EC ME EN EC ME EN EC ME EN HUES1  HUES6  HUES8  HUES9  HUES13  HUES28  HUES44  HUES45  HUES48  HUES49  HUES53  HUES62  HUES63  HUES64  HUES65  H1  H9  iPS11C  iPS15B  iPS17A  iPS18C  iPS27E CDH9  DMBX1  EN1  LMX1A  TRPM8  MYO3B  OLFM3  PAX3  ZBTB16  SOX1  NOS2  WNT1  NR2F1/2  NR2F2  PAX6  COL2A1  MAP2  POU4F1  SDC2  DRD4  PAPLN   ME d2  d5   ODAM  HAND1  ABCA4  CDX2  SNAI2  FOXF1  PDGFRA  TBX3  BMP10  HOPX  HEY1  FCN3  RGS4  HAND2  ESM1  CDH5  PLVAP  COLEC10  ALOX15  IL6ST  SST  NKX2-5  KLF5  TM4SF1  GATA4   EN d2  d5   CABP7  CDH20  FOXA1  RXRG  PHOX2B  HNF4A  POU3F3  HMP19  FOXP2  ELAVL3  SOX17  CPLX2  GATA6  CLDN1  HHEX  FOXA2  NODAL  LEFTY1  EOMES  LEFTY2 PL d2 d5 Fig. 7c,d ). On average, dEN differentiation had a higher background of ME and PL gene expression, which decreased following fluorescent activated cell sorting (FACS; Supplementary Fig. 7e ) 14 .
The differentiation potential 2D correlated well with established measures of differentiation efficiency, including abundance of the cell surface markers CD56 (dME and dEC) and CD184 (dEN) 9 . We quantified the percent CD56 positive cells for 11 cell lines and found a significant correlation (R ≥ 0.83, P < 10 −3 , Pearson correlation) between the pertinent ME and EC differentiation potential 2D of those lines, but no significant (R ≤ 0.35, P > 0.1, Pearson correlation) positive correlation with markers for the other germ layers (Fig. 4d) . This was also the case for CD184-positive cells and EN differentiation potential 2D . The lack of correlation in efficiency with the differentiation potential 2D of alternate lineages again argues that there is limited crosstalk in our germ layer marker expression. We also tested whether the three PiPSC lines that did not make embryoid bodies could differentiate into ectoderm in a directed manner. The negative EC differentiation potential 2D at day 5 ( Fig. 4e) indicates that they could not form EC. Again, we detected a high ME background signal characteristic of the fibroblast origin of these cells.
With the differentiated state as a reference, computing differentiation potential 2D either by using the unweighted Z-transform test or by averaging the t scores 7 lowers the overall correlation with 2D efficiency (Supplementary Fig. 8a-c) . It is also worth noting that in general we did not find expression at day 0 to be very predictive of the 2D or embryoid body differentiation potentials ( Supplementary  Fig. 8d ). Taken together, these results argue that the improved gene selection, using undifferentiated cells as a reference, and weighting of gene observations adds accuracy and flexibility to our computational analysis of the qPCR ScoreCard panel.
Utility of assay to quantify the effects of perturbations
The high proportionality between differentiation potential 2D and differentiation efficiency provides a quantitative tool for applications beyond line-to-line comparison.
First, we evaluated the effects of different small molecules on endoderm differentiation. We found that dEN protocols that substitute LiCl for WNT3A have a similar differentiation potential (Fig. 4f) . However, replacing activin A with the previously reported 15 compound IDE1 decreases LEFTY1 activation and the overall EN differentiation potential.
Next, we used short hairpin (shRNAs) to knock down transcriptional regulators of early differentiation, including EOMES 16 , GATA4 (ref. 13 ) and OTX2 (refs. 13,17) , in HUES64 cells. We observed reduced expression of several key lineage markers and a significant overall reduction in the differentiation potential 2D of cell lines after knockdown of EOMES (P = 1 × 10 −5 , Fisher's method) and GATA4 (P = 0.003, Fisher's method; Fig. 4g) , which is independent of the cell line used (Fig. 4h) . The knockdowns showed both significant reduction of EN marker expression and increase of ME markers (P ≤ 0.01, Fisher's method), in line with EOMES's known role in suppressing the mesoderm transcriptional program during endoderm differentiation 16 . Similarly, OTX2 knockdown showed lower expression of several key ectoderm markers and reduced EC differentiation potential 2D (P = 6 × 10 −5 , Fisher's method; Fig. 4i) , as well as higher expression of ME markers (P = 0.002, Fisher's method) during dEC differentiation, suggesting that OTX2 might also play a role in suppressing the mesoderm transcriptional program.
Finally, we wanted to quantify the effects of JQ1 (BRD4 inhibitor) given its previously reported role at 'super enhancers' 18 . Treatment of the HUES64 cell line with different concentrations of JQ1 during 12 days of embryoid body formation led to increased EN expression and differentiation potential EB (P < 0.01, weighted Z-method) (Fig. 4j) along with decreased EC and ME differentiation potential EB (Supplementary Fig. 8e ). This fits well with recent data showing that super enhancers are enriched for key regulators in EC and ME but not in EN 13 , which may explain the endoderm bias of JQ1-treated embryoid bodies.
Quantitative assessment of distinct culture conditions Our embryoid body and 2D experiments for multiple matching cell lines allowed us to compare these two established differentiation protocols. Scatter plot of the 2D weights versus embryoid body day 5 (Fig. 5a) or day 12 weights (Supplementary Fig. 9a) shows that the average differential expression of EC and ME gene markers were mostly correlated (R = 0.48, 0.73 for EC, ME), with some exception for EC (EN1, NR2F2) and ME (BMP10, NKX2-5, GATA4). In contrast, weights for EN markers were anti-correlated (R = −0.84), where several established markers of directed differentiation (FOXA2, and most upregulated genes were pluripotency and mesendoderm markers. Moreover, GATA4, EOMES, NODAL and LEFTY1,2 were found to decrease in expression in feeder-free culture, which may also contribute to their increased levels in 2D versus embryoid body differentiation. Displaying the distribution of mean expression differences for all markers within the four gene classes showed that pluripotent genes are more highly expressed (P = 7 × 10 −4 , weighted Z-method) in feeder-free culture (Fig. 5c) . In contrast, EN genes (P = 2 × 10 −6 ) and EN markers: ME markers: p o t e n t ia EC markers:
p o t e n t ia ME markers: 
protein R&D protein LT 6 0 -5 10 5 0 10 5 0 8 8 dME HUES64 ME markers: -∆∆C t, EBd12-PSC EN diff. potential EB j EOMES, NODAL, LEFTY1,2) showed decreased expression in embryoid bodies, which may relate to the different media signaling components used. For example, directed differentiation into dME uses BMP signaling, and GATA4 is known to act downstream of BMP signaling in heart development 19 , which could explain differences in BMP10 and GATA4 expression. Moreover, activin A signaling is crucial for dEN differentiation and proteins NODAL, LEFTY1,2 and EOMES are known downstream effectors 16 . In comparing embryoid body versus 2D undifferentiated samples, we noticed a substantial difference between hPSC lines grown on mouse embryonic fibroblast (MEF) feeder cells and those grown in feeder-free conditions. For 11 lines grown using both feeder and feeder-free culture, we computed the mean difference in expression per gene (Fig. 5b) and found that most significantly downregulated genes (P < 0.05, Wilcoxon signed rank test) were EN and ME markers npg A r t i c l e s to a lesser degree ME and EC genes (P < 0.05, weighted Z-method) are more highly expressed in cells on feeders, suggesting that culture on MEFs introduces higher background differentiation (Fig. 5c) . We observed a similar trend when considering the distribution of differentiation potential 2D difference (Supplementary Fig. 9b ).
Next we used our signature panels to quantify the effect of cell line adaptation due to repeated passaging in feeder-free culture. We compared the gene expression profiles of seven hESC lines cultured on Geltrex and after adaptation for one or more passages on Geltrex. The majority of EN and ME genes decreased in mean expression after adaptation, and the effect became more pronounced after six or more passages of adaptation (Fig. 5d) . In contrast, pluripotent and EC marker expression did not change substantially after Geltrex adaptation. To quantify the effect of hESC adaptation on subsequent differentiation, we calculated the mean expression difference during directed differentiation for each gene class and found that adapted lines were less efficient but more specific. For example, during dEN differentiation (Fig. 5e, right panel) , expression of EN markers was slightly lower in adapted cells, whereas background expression of ME and EC markers was significantly lower (P < 0.01, weighted Z-method). Lower background expression of alternate lineages was also observed for dME (Fig. 5e, middle panel) and dEC differentiation GATA6  FOXA2  LEFTY1  HNF1B  PRDM1  LEFTY2  PTHLH  FOXA1  GATA4  TBX3  NR2F1/2  NODAL  HNF4A  PDGFRA  CPLX2  POU3F3  ESM1  RXRG  RGS4  EOMES  NANOG  NR5A2  FGF4  WNT1  TRIM22  CXCL5 (e) Box plot of the distribution of mean expression difference between adapted and unadapted hESC lines following directed differentiation into dEC, dME and dEN. Gene expression differences were categorized into four gene classes (EC, ME, EN, PL). (f) Differentiation potential difference between adapted and unadapted hESC lines (first column) after directed differentiation into dEC, dME, dEN and for the undifferentiated control (right). Mean differences for all cell lines is shown on the bottom row. (g) Bar graph of genes with significantly (*P < 0.05, t-test) decreased expression in cell lines adapted versus unadapted to feeder-free tissue culture. Y axis measures the mean expression difference, averaged over seven matching cell line experiments.
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(left panel). Furthermore, we calculated the difference in differentiation potential 2D between adapted and unadapted cells for the seven cell lines (Fig. 5f) . Again, during dEN differentiation, EN potential 2D was lower on average, but ME and EC potentials were much lower. Similarly, dME and dEC differentiation were less efficient on average but more specific. Genes that were significantly downregulated (P < 0.05, t-test) owing to adaptation (Fig. 5g) include EN and ME markers that were also downregulated in adapted cells at day 0 as well as EC markers whose expression was not affected by adaptation before differentiation.
DISCUSSION
We describe a qPCR ScoreCard assay based on expression measurements of 96 genes, which is highly scalable, broadly accessible and 5-to 10-fold faster than the teratoma assay (Fig. 6a) . We further show that it is more reproducible than the teratoma assay, in part because of the inherent noise in quantifying sectioned stainings (which arises from limited sampling in two dimensions, unfocused scanning near folded tissue, variability of fixation, variability of antibody concentrations, the presence of host tissue, and the difficulty of classifying undifferentiated and primitive tissue types). We also introduce a computational approach for combining gene signatures in a meaningful and assay-dependent manner using the weighted Z-method, which presents several advantages over PluriTest 6 and the previous ScoreCard 7 ( Supplementary  Fig. 9c ). The combined statistic allows us to detect the significance of a cell line's ability to differentiate along each of the three germ layers. PluriTest separates pluripotent and differentiated samples along two dimensions-pluripotency and novelty score. As currently designed, it does not give an individual score for the three germ layers.
We provide an in-depth characterization of embryoid body formation, directed differentiation and common hPSC tissue culture conditions spanning 272 experiments (Supplementary Table 5 ). By improving our gene selection (Supplementary Fig. 3b ) and weighting gene observations, we increased the statistical power ( Supplementary  Figs. 4f and 7b), accuracy (Supplementary Fig. 8a,b) and flexibility of the panel toward use in numerous applications. These include small-molecule screens for dEN and dME protocols, characterizing feeder versus feeder-free culture and their effects on directed differentiation and quantifying the effect of genetic perturbation of key lineage regulators during directed differentiation.
Our computational measure of differentiation potential 2D correlated well with established metrics for differentiation efficiency. Moreover, we performed feature selection using the Lasso regression algorithm to calculate the minimum number of markers needed to accurately fit differentiation potential 2D and 2D efficiency (Supplementary Fig. 10 ). We found that six to eight markers per germ layer were sufficient to calculate a near-perfect fit to differentiation potential 2D ( Supplementary  Fig. 10c, Supplementary Table 4 ) and two to three markers for predicting directed differentiation efficiency (Supplementary Fig. 10f) . We also observed high correlation with differential potential 2D and differentiation efficiency when using a smaller subset of germ layer markers (Fig. 6b) and even down to individual genes (Fig. 6c) . This reduction analysis will help guide users to also develop alternative cell line tests using selected markers combined with flow cytometry or possibly reduced RT-qPCR panels.
A major focus of hPSC research is the generation of differentiated cell types relevant to disease therapy. The qPCR ScoreCard provides some information in this direction, but was specifically designed for the rapid assessment of molecular and functional pluripotency. One could envision new versions that would include unique gene expression signatures at other developmental time points in order to predict the capacity to differentiate into specific cell fates of interest.
METHODS
Methods and any associated references are available in the online version of the paper. Figure 6 Future outlook of qPCR expression assay. (a) Schematic of the timelines for performing teratoma formation (top) versus qPCR expression assay for assessing hPSC utility (bottom). (b) Pearson correlation coefficient (R) of the differentiation potential 2D (calculated using a subset of EN, ME and EC markers) is plotted when correlated with the differentiation potential 2D using all markers (left) or with 2D efficiency (right). Subsets of marker genes and weights were chosen using the Lasso regression algorithm (Online Methods). R increases with number of marker genes used (x-axis). (c) Pearson correlation coefficient (R) of 2D efficiency versus the differentiation potential 2D calculated for each germ layer (left, dEC; middle, dME; right, dEN) using the expression of individual markers, using all markers (Z w,GS ) and using 2-3 marker genes and weights learned by Lasso regression (right-most bars).
npg ONLINE METHODS
Recommended protocol for the qPCR ScoreCard assay. We have provided a detailed description of the current ScoreCard design and various experimental details including many useful applications. Interested researchers have several options to use our results and analysis: 1. Life Technologies offers a commercial version (TaqMan hPSC Scorecard) that 100% matches the described qPCR ScoreCard panel used for all 272 experiments in this study. The company website provides a detailed 5-step protocol including recommended reagents for the day 5 embryoid body protocol, details on assay design and analysis tools.
This option provides a common and comparable standard across laboratories with the least specialized expertise required of individual users.
2. We provide many details on the various embryoid body time points, the 2D differentiation and the downstream effects on the results and analysis. Users can obtain the 384-well TaqMan hPSC Scorecard Panel plates from Life Technologies and use a more customized assay design. As described, informative results can be obtained within 5 days, but extended time for embryoid body formation (day 12) will increase confidence (we provide culture details in the "Tissue culture" and "Embryoid body differentiation" sections below). We recommend using 1 µg of total RNA per sample (see "RNA extraction, reverse transcription and Taqman qPCR" section for more detail). For analysis, we advise using normalization based on the average between five control genes (data normalization) and using a pluripotent reference of 23 hPSC lines at day 0 (Supplementary Table 5 ). Calculation of differential potential should be carried out as described here ("Computing differentiation potential") using weights calculated for day 12 embryoid bodies (Supplementary Table 4 ).
This option requires additional computational skills compared with option 1, and the results are not directly comparable to those of other laboratories using a different strategy.
3. We provide an extensive description of the gene sets and the regression analysis to define the minimal number of informative genes. Users could choose to design their own TaqMan plates using the reduced number of genes and then follow most of the step described in option 2 and the provided Supplementary Code.
This option requires more advanced computational skills, and the results are also not as directly comparable to those of other laboratories using a different strategy.
Immunofluorescence and phase images. hPSCs were passaged on Geltrex (Life Technologies)-coated plates, and cells were cultured in mTeSR1 medium (Stem Cell Technologies). Cells were then fixed in 4% paraformaldehyde (PFA) for 15 min at room temperature. Permeabilizing and blocking were done in 5% bovine serum albumin (BSA) and 1% Triton X-100 (Sigma) in 1× phosphatebuffered saline (PBS; Life Technologies) for 30 min. Cells were stained with mouse anti-oct3/4 primary antibody (1:1,000 dilution; BD Transduction Laboratories, 611202) at 4 °C overnight. The secondary antibody (goat antimouse DyLight 488; Jackson Immunoresearch, 115-485-003; 1:1,000 dilution) was applied for 2 h at room temperature. TRA1-60 double staining was performed using StainAlive mouse anti-Human antibody (1:200 dilution; Stemgent, 090068) at room temperature for 2 h. The nuclei were stained with Hoechst 33342 (1 µg/ml; Life Technologies, 33342). Cells were imaged using Olympus IX71 microscope and MetaMorph Advanced software.
RNA extraction and RNA-seq. For measuring expression level, RNA was isolated from hESCs using TRIzol (Invitrogen, 15596-026), further purified with RNeasy columns (QIAGEN, 74104) . RNA-seq library construction and data analysis were carried out as described previously 9 .
Tissue culture. Cell culture was done as reported previously 9 . Briefly, hPSCs were maintained on irradiated Murine Embryonic Fibroblasts (MEFs, plated at density of 15,000 cells/cm 2 ; Global Stem). Cells were cultured in KO DMEM (Life Technologies) medium supplemented with 20% Knockout Serum Replacement (KOSR; Life Technologies), 1% GlutaMAX (Life Technologies), 1× MEM Non-Essential Amino Acid (Life Technologies), 10 ng/ml bFGF (Millipore), and 55 µM 2-mercaptoethanol. Cells were passaged every 4-5 days using 1 mg/ml Collagenase IV (Life Technologies). All cell lines were tested for mycoplasma contamination. HUES cell lines were obtained through Harvard University, SMA patient iPSC and PiPSC lines were obtained from the Rubin laboratory, and the remaining cell lines were obtained from the Melton and Eggan laboratories.
Teratoma formation. Teratoma formation was performed by the Genome Modification Facilities. hPSC lines HUES9, HUES53, HUES64, H1, H9 and iPSC1-51C were expanded in culture and each line was injected into the kidney capsules of three immuno-suppressed mice, using 1 million cells per animal. The teratomas were isolated 7-8 weeks following injection. Next, the teratomas were fixed in 4% paraformaldehyde (PFA) pH 7.4 for 24 h, embedded in paraffin, sectioned at a thickness of 10-12 µm, and stained with hematoxylin and eosin for examination. The Histology Core Facility at Harvard Stem Cell Institute performed the steps following teratoma formation.
Teratoma analysis. Histological analysis and quantification of the different germinal layers in the teratomas were done using the Leica automated scanner (SCN400 F) and the Leica Biosystems Tissue Image Analysis software (Version 4.0.4). A board-certified pathologist examined the tissue and annotated all areas of mesoderm, ectoderm and endoderm on all of the tissue present on the scanned slide. Annotation was done blindly, without prior knowledge of the identity of the cell lines and samples. Specialized tissues such as muscle, nerve, cartilage, neuroectoderm and bone were given a separate annotation (Supplementary Table 2 ) before being summed into the three germ layers for final analysis. The amount of tissue present in each germinal layer was quantified by measuring the number of cell nuclei within each annotation, using the "Measure Stained Cell" algorithm. This algorithm was custom-designed to measure hematoxylin-stained nuclei (tissue threshold = 220, nuclei heterogeneity = 2, strength of nuclear counterstaining = 2, nuclear window radius size = 50, maximum cell radius = 100, % of stained area in a nucleus cutoff = 10%, strong/moderate/weak nuclear staining intensity cutoff = 173-203, nuclear staining intensity cutoff = 220). The nuclei count for all annotation was automated, using the same algorithm. For the quantification of total cell nuclei within each annotation, moderately and strongly stained nuclei were added together; weakly stained nuclei were not used in the analysis as these nuclei often did not represent true nuclei (Fig. 1c) .
Immunohistochemistry and antibody staining. We picked three antibodies for each germ layer (total of nine antibodies) that were uniquely expressed in our directed differentiation data, reasoning that as they are unique markers of early development they should be a good marker in teratomas, which often contain tissues that are not fully differentiated and matured in structure. For each antibody, we performed immunohistochemistry at different dilutions and picked one antibody per germ layer with the best specificity in staining, independent of our pathological analysis. FOXA2, HAND2 and PAX6 were hence chosen in this manner.
Immunohistochemical stainings for FOXA2 (R&D Systems AF2400, 1:500), HAND2 (Abcam ab60037, 1:100) and PAX6 (Abcam ab5790, 1:800) were carried out by the Histology Core Facility at Harvard Stem Cell Institute. In summary, PFA-fixed and unfixed teratoma cryosections were mounted on slides. Unfixed sections were thawed for 10 min at room temperature and then fixed in cold acetone for 2 h. Antigen retrieval for both acetone-fixed and formalin-fixed sections was achieved by boiling in citrate buffer (10 mM citric acid, 0.05%, pH 6) for 15 min. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide for 20 min. Sections were blocked in 3% normal horse serum for 20 min and then incubated overnight at 4 °C with either FOXA2, HAND2 or PAX6 primary antibodies at dilutions indicated above. Secondary antibody incubation was for 30 min at room temperature with either anti-goat (Vector Labs PK-4005, 1:200, for FOXA2) or anti-rabbit (Vector Labs BA-1000, 1:200, for HAND2 and PAX6). The ABC amplification system (Vector Labs, PK-4005) and DAB substrate detection (Vector Labs, sk-4100) were used following the provided kit protocols. Standard washes were used for all procedures. The slides were counterstained in hematoxylin for 2 min, dehydrated in a series of alcohol and water washes, and coverslipped.
Taqman qPCR signature panel design. We selected gene markers for each of the four gene categories (EC, ME, EN, PL) based on uniqueness of expression for that marker in published RNA-seq for directed differentiation of hESC line npg HUES64 into purified germ layer populations 9 . Uniqueness of expression for each gene was defined as the difference in expression for each gene in a given category and the closest expression level of that gene in the other three cell types. For example, minimal uniqueness of expression of EC marker k with log 2 (FPKM) expression value dEC k in a purified ectoderm population dEC (see Supplementary Fig. 3b ) can be calculated as follows:
The expression values dME k , dEN k , hPSC k represent log 2 (FPKM) expression values in purified mesoderm, endoderm and pluripotent populations, respectively. Similarly the mean uniqueness of expression of the same ectoderm marker k can be calculated as follows:
For the final panel design, genes were ranked based on having the highest minimal uniqueness of expression and selected with priority given to highly expressed genes, to genes also uniquely expressed in Nanostring data 9 from the same cell types, and to known markers from the literature. Mesendoderm (MS) markers were selected using recent RNA-seq data from an earlier HUES64-directed differentiation mesendoderm population 13 in the same manner, but now comparing uniqueness of expression to hPSC and the three germ layers (four cell types). Genes known to be invariant in expression level were selected as control genes and further filtered to use for data normalization (see below). Identified panel was used to design the set of 96 genes in replicates of 4 to generate a 384-well panel that is commercially available (Life Technologies). Subsequent experiments were carried out using the commercially available product.
Correlation analysis. The Pearson correlation coefficient (R) between biological and technical replicates was computed in a pairwise manner using all genes with non-empty threshold cycle (C t ) expression values for both samples.
The distributions of C t values are Gaussian. Analysis was performed using MATLAB version 8.1 release name R2013a, built-in function corrcoef.m with default settings and 'rows' parameter set to 'pairwise' .
Data normalization.
We normalized the data using housekeeping genes that we found most invariant in expression between experiments and most unbiased in differentiation into the three germ layers. To quantify each gene's expression variability, we measured all possible differences in expression between four cell types (dEC, dME, dEN, hPSC), averaged across 21 independent 2D experiments (Supplementasry Table 3 ). We found the following five gene probes to be the most invariant in expression on average during germ layer differentiation-SMAD1, EP300, CTCF, ACTB and ACTB. Moreover, we calculated the average bias between different germ layers for these five genes (Supplementary Table 3 ). In all cell type comparisons, the average bias for a given comparison was half of a C t value or less. As a result, we decided to normalize the data using the average expression level of the five control genes. This normalization factor was subtracted from the C t value of each gene per experiment.
Embryoid body differentiation. Embryoid body formation was done as previously described 7 with slight modifications. Briefly, hPSCs were expanded in 10-cm 2 dishes on irradiated MEFs. Once the cells were confluent, we harvested them using 1 mg/ml collagenase IV and washed three times with PBS. We collected a portion of the cells as a day 0 undifferentiated control, and the remainder of the cells were evenly split into 6-well low attachment dishes (Corning) for embryoid body formation in KO DMEM medium with 20% KOSR, 1% GlutaMAX and 1× MEM Non-Essential Amino Acid. The media was changed every 2-3 days. Embryoid bodies were collected at days 2, 5 and 12, washed three times with PBS, flash frozen as pellets and stored at −80 °C.
Derivation of partially reprogrammed cell lines. Adult fibroblasts (samples from patients with Spinal Muscular Atrophy (SMA) procured under IRBapproved protocols) were plated at a density of 100,000 cells into one well of a 6-well plate. The cells were transduced for two consecutive days with four retroviruses (1 ml of MIG-Oct4, 1 ml of MIG-Klf4, 1 ml of MIG-Sox2 and 200 µl of MIG c-Myc). Five days later, the transduced fibroblasts were collected and replated on feeder (irradiated mouse embryonic fibroblasts). Beginning the following day, the cells were fed daily with hESC medium (400 ml DMEM/F12; 100 ml KO-SR; 2× l-glutamine, 1× MEM-NEAA, 10 ng/ml bFGF) until colonies were ready to pick. Fully reprogrammed iPSC lines were identified by viral GFP-silencing and characteristic pluripotent stem cell colony morphology. PiPSC lines were picked based on uncharacteristic shape and GFP expression.
RNA extraction, reverse transcription and Taqman qPCR. Total RNA was extracted from frozen cell pellets using Ambion Pure Link RNA Mini Kit (Life Technologies). Eight cDNA reactions were set-up from 1 µg of total RNA per sample using High-Capacity cDNA RT Kit (Life Technologies). qPCR was performed with 384-well TaqMan hPSC Scorecard Panel plates (Life Technologies) that were run on Applied Biosystems ViiA7 instruments and using Viia7 RUO software for exporting C t values.
Computing differentiation potential. To quantify the differentiation potential of cell lines using embryoid body differentiation data, we built on our previous computational analysis 3 . Specifically, for each gene in an embryoid body experiment, we compared its expression relative to the expression of that gene before embryoid body differentiation (day 0) for 23 hPSC reference lines and calculated a P value P k using the one-tailed, one sample t-test. The distribution of C t expression values for the reference set closely resembled a Gaussian distribution, as has been observed for gene expression data in general, which justifies the use of the t-test. The resulting P values are then combined within each gene set GS (PL, EN, ME, or EC) using the weighted Z-method
where Z k = Φ −1 (1 -P k ), P k is the P value for the k-th gene in each gene set GS that contains N genes, Φ and Φ −1 denote the standard normal cumulative distribution function and its inverse, w k are the corresponding weights for the k-th gene, and r k,j is the correlation of Z k and Z j . Weights were set to the C t expression difference between day 5, 12 of embryoid body formation and day 0, averaging across experiments for 23 cell lines (Supplementary Table 4) . This can be interpreted as the average differentiation power of each gene during embryoid body differentiation. Genes with negative weights were excluded from the embryoid body analysis (w k = 0). The correlation coefficients r k,j were estimated using Z k from all day 12 embryoid body reference cell lines. The combined P value for each gene set GS, P w,GS , gives a statistical basis for rejecting the null hypothesis that a cell line cannot differentially express gene markers characteristic for a given germ layer. We refer to the weighted Z-test standard normal deviate Z w,GS = Φ −1 (1 -P w,GS ) for each gene set GS as the differentiation potential EB , as it measures the distance traveled away from a pluripotent state. The weighted Z-test assumes one-tailed P values. To satisfy this assumption, we use the one-tailed version of the one sample t-test. Partially reprogrammed cell lines had a number of missing values for differentiation markers due to low expression of these genes. Hence, for these samples we assigned a C t value of 45, which estimates the highest measureable C t value, for all markers with missing values.
To calculate the differentiation potential 2D , we made several small modifications to our computational approach. First, we changed the reference set to the pluripotent populations cultured in feeder-free conditions for 11 established hPSC lines (top 11 lines in Fig. 4c) . Also, we assigned the 2D weights based on minimal uniqueness of expression for each marker among the four cell types (see Taqman qPCR signature panel design), averaged across all cell lines. The correlation terms r k,j for all EC markers were estimated using Z k from all 14 dEC experiments (cell lines in Fig. 4c) . Similarly, the ME, EN and PL marker correlation terms r k,j were estimated using all 14 dME, dEN and hPSC experiments, respectively. Analysis was performed using MATLAB version 8.1 release name R2013a, using functions provided in the Supplementary Code. npg instrument. C t values were normalized using two probes of the ACTN housekeeping gene. Other normalization genes were not used here, since they are reduced in expression in the KDs. We used pLKO.1 cloning vector with the following target sequences for EOMES (CCGTTTCAGAAGGAGACATTT, CCCAGATGATAGTCTTACAAT, CCATAAAGTGTGAGGACATTA), GATA4 (CCAGAGATTCTGCAACACGAA, CGAGGAGATGCGTCCCATCAA, CCCGGCTTACATGGCCGACGT) and OTX2 (GCACTGAAACTTTACGACA AA, GCTGGCTCAACTTCCTACTTT, CCATGACCTATACTCAGGCTT). The shRNA control cell lines targeted gene products not present in the human genome using the same cloning vector with the following target sequences: TGACCCTGAAGTTCATCTGCA (GFP) and CACTCGGATATTTGATATGTG (LUCIFERASE).
Computing shRNA knockdown P values. To compute significance in change of differentiation potential in all knockdown experiments we set the relevant control lines as the reference set and computed the differentiation potential 2D and corresponding P value for each shRNA knockdown experiment. The resulting P value calculation accounted for dependencies between genes as described above. For expected decrease in gene expression compared to the reference we used the left-sided, one sample t-test and for an expected increase we used the right-sided, one sample t-test. Analysis was performed using MATLAB version 8.1 release name R2013a, using the scorecardv5d0.m function provided in the Supplementary Code. P values for the differentiation potential 2D of the three independent shRNA knockdown experiments were then combined using Fisher's method to compute the total P value of the knockdown lines compared to control lines.
Feeder versus feeder-free culture analysis. To compare feeder and feederfree culture conditions, for each gene we computed the mean difference in normalized C t expression, averaged over 11 matching cell lines grown in both culture conditions. Significance of the difference in expression across all cell lines was calculated both using the paired t-test and the Wilcoxon signed rank test (non-parametric), with both methods yielding very similar results. The distributions of mean difference in normalized C t expression were then displayed for each gene set (EC, ME, EN, PL) using box plots.
To quantify the effect of cell line adaptation due to repeated passaging in feeder-free culture, for each gene we again computed the mean difference in normalized C t expression, averaged over 7 matching cell lines. To quantify the effect of hESC adaptation on subsequent differentiation, for each gene we calculated the mean expression difference during dEC, dME and dEN differentiation. The distributions of mean difference in normalized C t expression were then displayed for each gene set (EC, ME, EN, PL) and each experiment class (hESC, dEC, dME,dEN) using Box plots. Analysis was performed using MATLAB version 8.1 release name R2013a, using built-in functions ttest.m and signrank.m with 'tail' parameter set to 'both' .
To compute significance of the distribution of mean expression difference for each gene class, we combined the paired t-test P values for all genes within a gene class using the weighted Z-method, as described above. The resulting P values calculation accounted for dependencies between genes. For expected decrease in gene expression compared to the reference we used the left-sided, paired t-test and for an expected increase we used the rightsided, paired t-test. Analysis was performed using MATLAB version 8.1 release name R2013a, using the scorecardv5d0.m function provided in the Supplementary Code. Lasso regression fitting. We performed Lasso regression algorithm to find the most sparse set of coefficients within the EC, ME, EN and PL gene sets that best fit the differentiation potential EB of the 23 cell lines in the day 12 embryoid body reference, the differentiation potential 2D of the 14 cell lines in Figure 4c and the 2D efficiency measures (Fig. 4d) . Lasso was fit to the standard normal deviates Z k = Φ −1 (1 -P k ), where P k is the P value for the k-th gene in each gene set GS calculated using the one-tailed, one sample t-test relative to the reference set (see "Computing differentiation potential") and Φ −1 denote the inverse standard normal cumulative distribution function (Fig. 2a) . For each lambda we compute the Lasso regression coefficients based on all the data and the corresponding Mean Squared Error (MSE) for that fit. We then used fivefold cross validation (where 80% of the data was used for training and 20% for testing) to estimate the standard error of the MSE for each lambda fit. The Lasso coefficients chosen for all analyses were the ones with the largest lambda such that the MSE is within on standard error of the minimum MSE (labeled "coef_1SE" in Supplementary Table 4 ). This lambda makes the sparsest model within one standard error of the minimum MSE. Grey error bars in the MSE plots ( Supplementary Figs. 5 and 10) indicate the standard error computed using the cross-validation for each value of lambda. The green circles indicate the Lambda with a minimum MSE. The blue circles indicate the largest lambda such that the MSE is within on standard error of the minimum MSE. We found that the coefficients chosen within one standard error of the minimum MSE explained at least 99% of the differentiation potential variance (R 2 ≥ 0.99). We find that 5-12 markers per germ layer are sufficient to calculate a near perfect fit to differentiation potential EB (Supplementary Fig. 5c ), 6-8 markers for 2D differentiation potential (Supplementary Fig. 10c ) and 2-3 markers for predicting 2D efficiency (Supplementary Fig. 10f ). The Lasso fits to 2D efficiency using 2-3 genes correlated at R ≥ 0.94 for all three germ layers, which was higher than the correlation with the corresponding 2D differentiation potential scores. Analysis was performed using MATLAB version 8.1 release name R2013a, using built-in functions lasso.m with parameter 'CV' set to 5 and lassoPlot.m with parameter 'PlotType' set to 'CV' .
Marker reduction analysis.
To assess the predictive power of our assay using a subset of markers (Fig. 6b,c) , we calculated the differentiation potential 2Dsubset using a subset of EN, ME and EC marker genes and then found the Pearson correlation coefficient (R) of the differentiation potential 2Dsubset with the overall differentiation potential 2D using all markers and with the 2D efficiency, described in the FACS analysis section. Subsets of marker genes and corresponding weights were chosen using Lasso regression algorithm fits as described above at different values of lambda. Correlations to the overall differentiation potential 2D and 2D efficiency for all lambdas with n nonzero coefficients were averaged to obtain one correlation value for all fits with n markers.
We also measured the Pearson correlation coefficient (R) of 2D efficiency versus the standard normal deviate Z k = Φ −1 (1 -P k ) for each individual gene k, where P k is the P value for the kth gene calculated using the one-tailed, one sample t-test relative to the reference set (see Computing differentiation potential) and Φ −1 denote the inverse standard normal cumulative distribution function. These single gene correlations are displayed in Figure 6c. npg
